OR WAIT null SECS
Fera Pharmaceuticals is now shipping erythromycin and bacitracin ophthalmic ointments.
New York-Fera Pharmaceuticals is now shipping erythromycin and bacitracin ophthalmic ointments.
"Fera has made the completion of erythromycin 1 g manufacturing transfer a priority, responding to the market shortage," said Frank DellaFera, president of the company.
The company expects to have available the 3.5-g tube size in single and carton sizes soon.
The manufacturing transfer for the balance of the line-including bacitracin zinc and polymixin B sulfate; gentamicin sulfate, neomycin and polymyxin B sulfates, and bacitracin zinc; neomycin and polymyxin B sulfates and dexamethasone; neomycin and polymyxin B sulfates, bacitracin zinc, and hydrocortisone acetate-is under way.
Fera expects them to be available later this year.